162 related articles for article (PubMed ID: 32786057)
1. Diacylglycerol acyltransferase 1/2 inhibition induces dysregulation of fatty acid metabolism and leads to intestinal barrier failure and diarrhea in mice.
Takemoto K; Fukasaka Y; Yoshimoto R; Nambu H; Yukioka H
Physiol Rep; 2020 Aug; 8(15):e14542. PubMed ID: 32786057
[TBL] [Abstract][Full Text] [Related]
2. Dgat1 and Dgat2 regulate enterocyte triacylglycerol distribution and alter proteins associated with cytoplasmic lipid droplets in response to dietary fat.
Hung YH; Carreiro AL; Buhman KK
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jun; 1862(6):600-614. PubMed ID: 28249764
[TBL] [Abstract][Full Text] [Related]
3. Role of diacylglycerol O-acyltransferase (DGAT) isoforms in bovine hepatic fatty acid metabolism.
Yang W; Wang S; Loor JJ; Lopes MG; Zhao Y; Ma X; Li M; Zhang B; Xu C
J Dairy Sci; 2022 Apr; 105(4):3588-3600. PubMed ID: 35181144
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.
Maciejewski BS; LaPerle JL; Chen D; Ghosh A; Zavadoski WJ; McDonald TS; Manion TB; Mather D; Patterson TA; Hanna M; Watkins S; Gibbs EM; Calle RA; Steppan CM
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G958-69. PubMed ID: 23558010
[TBL] [Abstract][Full Text] [Related]
5. Hepatic synthesis of triacylglycerols containing medium-chain fatty acids is dominated by diacylglycerol acyltransferase 1 and efficiently inhibited by etomoxir.
Wunderling K; Leopold C; Jamitzky I; Yaghmour M; Zink F; Kratky D; Thiele C
Mol Metab; 2021 Mar; 45():101150. PubMed ID: 33359403
[TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells.
Wurie HR; Buckett L; Zammit VA
FEBS J; 2012 Sep; 279(17):3033-47. PubMed ID: 22748069
[TBL] [Abstract][Full Text] [Related]
7. Diacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats.
Schober G; Arnold M; Birtles S; Buckett LK; Pacheco-López G; Turnbull AV; Langhans W; Mansouri A
J Lipid Res; 2013 May; 54(5):1369-84. PubMed ID: 23449193
[TBL] [Abstract][Full Text] [Related]
8. Acylation of acylglycerols by acyl coenzyme A:diacylglycerol acyltransferase 1 (DGAT1). Functional importance of DGAT1 in the intestinal fat absorption.
Cheng D; Iqbal J; Devenny J; Chu CH; Chen L; Dong J; Seethala R; Keim WJ; Azzara AV; Lawrence RM; Pelleymounter MA; Hussain MM
J Biol Chem; 2008 Oct; 283(44):29802-11. PubMed ID: 18768481
[TBL] [Abstract][Full Text] [Related]
9. The Role of Diacylglycerol Acyltransferase (DGAT) 1 and 2 in Cardiac Metabolism and Function.
Roe ND; Handzlik MK; Li T; Tian R
Sci Rep; 2018 Mar; 8(1):4983. PubMed ID: 29563512
[TBL] [Abstract][Full Text] [Related]
10. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology.
Amin NB; Saxena AR; Somayaji V; Dullea R
Clin Ther; 2023 Jan; 45(1):55-70. PubMed ID: 36690550
[TBL] [Abstract][Full Text] [Related]
12. The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2.
Qi J; Lang W; Geisler JG; Wang P; Petrounia I; Mai S; Smith C; Askari H; Struble GT; Williams R; Bhanot S; Monia BP; Bayoumy S; Grant E; Caldwell GW; Todd MJ; Liang Y; Gaul MD; Demarest KT; Connelly MA
J Lipid Res; 2012 Jun; 53(6):1106-16. PubMed ID: 22493088
[TBL] [Abstract][Full Text] [Related]
13. Treatment of human skeletal muscle cells with inhibitors of diacylglycerol acyltransferases 1 and 2 to explore isozyme-specific roles on lipid metabolism.
Løvsletten NG; Vu H; Skagen C; Lund J; Kase ET; Thoresen GH; Zammit VA; Rustan AC
Sci Rep; 2020 Jan; 10(1):238. PubMed ID: 31937853
[TBL] [Abstract][Full Text] [Related]
14. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis.
Buhman KK; Smith SJ; Stone SJ; Repa JJ; Wong JS; Knapp FF; Burri BJ; Hamilton RL; Abumrad NA; Farese RV
J Biol Chem; 2002 Jul; 277(28):25474-9. PubMed ID: 11959864
[TBL] [Abstract][Full Text] [Related]
15. Dictyostelium discoideum Dgat2 can substitute for the essential function of Dgat1 in triglyceride production but not in ether lipid synthesis.
Du X; Herrfurth C; Gottlieb T; Kawelke S; Feussner K; Rühling H; Feussner I; Maniak M
Eukaryot Cell; 2014 Apr; 13(4):517-26. PubMed ID: 24562909
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency.
van Rijn JM; Ardy RC; Kuloğlu Z; Härter B; van Haaften-Visser DY; van der Doef HPJ; van Hoesel M; Kansu A; van Vugt AHM; Thian M; Kokke FTM; Krolo A; Başaran MK; Kaya NG; Aksu AÜ; Dalgıç B; Ozcay F; Baris Z; Kain R; Stigter ECA; Lichtenbelt KD; Massink MPG; Duran KJ; Verheij JBGM; Lugtenberg D; Nikkels PGJ; Brouwer HGF; Verkade HJ; Scheenstra R; Spee B; Nieuwenhuis EES; Coffer PJ; Janecke AR; van Haaften G; Houwen RHJ; Müller T; Middendorp S; Boztug K
Gastroenterology; 2018 Jul; 155(1):130-143.e15. PubMed ID: 29604290
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
18. Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes.
Li C; Li L; Lian J; Watts R; Nelson R; Goodwin B; Lehner R
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1080-91. PubMed ID: 25792450
[TBL] [Abstract][Full Text] [Related]
19. DGAT2 partially compensates for lipid-induced ER stress in human DGAT1-deficient intestinal stem cells.
van Rijn JM; van Hoesel M; de Heus C; van Vugt AHM; Klumperman J; Nieuwenhuis EES; Houwen RHJ; Middendorp S
J Lipid Res; 2019 Oct; 60(10):1787-1800. PubMed ID: 31315900
[TBL] [Abstract][Full Text] [Related]
20. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
